Alira Health Starts a New Collaboration with Mark Inigo Jones on Parallel Trade Management

News
Published on:
August 29, 2020

BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, is pleased to announce a new collaboration with Mark Inigo Jones, an industry leader in European parallel trade of pharmaceutical products. Mark brings his extensive knowledge, implementation, and operational experience in effective strategies for parallel trade management initiatives to the firm’s Market Access practice and Parallel Trade practice. The firm’s clients, which includes over 50% of the top 100 pharmaceutical companies, will benefit from this enhanced service offering, which aligns closely with the firm’s market access, pricing, and reimbursement services.

Shaped on best practices developed through his years at Novartis, Mark’s collaboration with Alira Health rounds out a new team focused on supporting clients in increasing profitability and protecting brand reputation through dedicated initiatives for effective parallel trade management.  Using an innovative, data-driven approach, the Alira Health team has extensive operational experience and a record of achievement in supporting clients as they develop and implement successful EU-compliant distribution strategies. A cornerstone of Alira Health’s Parallel Trade practice is to help companies develop their internal capabilities in effective parallel trade corporate governance.

Previously, Mark was the Head of European Trade at Novartis, where he developed and implemented the corporate strategy that lead to the largest reductions in parallel trade of any pharmaceutical peer company. During his time at Novartis, Mark managed portfolios for Alcon and GSK Oncology, where he achieved an increase of the profitability of the brands up to 30 % within 12 months of taking responsibility for their distribution.

Mark holds a variety of master’s degrees in related fields, including EU Competition Law from Kings College London, Health Economics from the London School of Economics, and Finance from The London School of Business. He has also lectured on Parallel Trade at the European Center of Pharmaceutical Medicine course at the University of Basel.

For more information about Alira Health’s Parallel Trade services

Click here

Related news

MedTech
Events October 12, 2021
Event: HLTH Conference
Join us at HLTH October 17-20 in Boston, MA
Market Access
Publications September 28, 2021
Alira Health Published in Business Development & Licensing Journal
Experts from the Alira Health team recently shared their thoughts regarding the importance of market access insights for the success of licensing operations with professionals from(...)
MedTech
Publications September 27, 2021
A Robotic-Assisted Surgery (RAS) Review: Clinical Landscape, Commercial Arena, and Future Outlook
Today’s $7B global Robotics-Assisted Surgery (RAS) market is projected grow to $30B in 2030. Download Alira Health’s Full RAS report to understand adoption dynamics today – technologies,(...)
MedTech
Multimedia August 6, 2021
Alira Health’s Transformation Talks: Overcoming Challenges to Reimbursement in Robotic Surgery for the French Market
Our latest Alira Health Transformation Talks is all about Robotic Surgery.
MedTech
Events August 5, 2021
Event: The MedTech Conference
Join the Alira Health team at AdvaMed September 29-30, 2021 in Minneapolis, MN.
MedTech
News July 27, 2021
Alira Health Announces it Role as Strategic Advisor to Montagu Private Equity
We are pleased to have advised Montagu PE in the acquisition of Intech, a target active in the design and manufacturing of complex reusable surgical instrumentation for Minimal Invasive(...)
MedTech
News July 22, 2021
Alira Health Welcomes Fredrik Nyberg as Partner and Regional Head
We are pleased to announce that Fredrik Nyberg has joined Alira Health as Partner and Regional Head

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.